ABBV vs COST: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Costco Wholesale Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-08.
AbbVie Inc. · Healthcare
$261.07
+1.2% upside to fair value
Grade C
High Quality
VS
Costco Wholesale Corporation · Consumer Defensive
$947.50
-1.4% upside to fair value
Grade C
High Quality
QuantHub Verdict
ABBV has more upside to fair value
(+1.2%).
COST trades at a lower forward P/E
(47.6x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
COST |
| Current Price |
$261.07 |
$947.50 |
| Fair Value Estimate |
$264.30 |
$933.84 |
| Upside to Fair Value |
+1.2%
|
-1.4%
|
| Market Cap |
$461.3B |
$420.2B |
| Forward P/E |
128.0x
|
47.6x
|
| EV / EBITDA |
31.0x
|
28.3x
|
| Price / Sales |
7.3x
|
1.4x
|
| Price / FCF |
22.1x
|
47.7x
|
| Revenue Growth YoY |
+12.4%
|
+11.6%
|
| Gross Margin |
70.7%
|
12.9%
|
| Operating Margin |
27.6%
|
3.8%
|
| Return on Equity |
68.0%
|
28.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.52%
|
2.1%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
AbbVie Inc. is a leading healthcare company specializing in drug manufacturing with a strong focus on immunology and aesthetics. The company is transitioning from its historical Humira dominance, which has faced loss of exclusivity, toward high-growth assets like Skyrizi and Rinvoq that are driving robust revenue growth of 12.4% in the most recent quarter. Despite strong revenue growth and a dura…
Costco Wholesale Corporation operates as a membership-only warehouse club offering a wide range of merchandise at low prices. The company exhibits high business quality with a durable competitive moat driven by cost advantages, strong brand loyalty, and efficient operations, reflected in a robust ROE of 28.3% and solid revenue growth of 11.6% in the most recent quarter. Despite these strengths, t…
Accumulation Zones
| Metric |
ABBV |
COST |
| Zone Low |
$198.23 |
$700.38 |
| Zone High |
$224.66 |
$793.76 |
| In Buy Zone? |
No
|
No
|